Sort
27,075 grants matching “cholesterol”
Mechanisms of Annexin A6 Mediated Basal-like Breast Cancer Progression
$363,750Amos Malle Sakwe · Meharry Medical College · SC1 · FY2022 · GM
Experimental Pathology of Developing Nervous System
$363,750University Of North Carolina Chapel Hill · R01 · FY2002 · NS
Experimental Pathology of Developing Nervous System
$363,750University Of North Carolina Chapel Hill · R01 · FY2003 · NS
Defective isoforms of ApoE induce atherogenesis via unfolded protein responses
$363,750Hong Yang · Meharry Medical College · SC1 · FY2018 · HL
Defective isoforms of ApoE induce atherogenesis via unfolded protein responses
$363,750Hong Yang · Meharry Medical College · SC1 · FY2016 · HL
Mechanisms of Annexin A6 Mediated Basal-like Breast Cancer Progression
$363,750Amos Malle Sakwe · Meharry Medical College · SC1 · FY2024 · GM
Translational Silencing in Monocytes: Role of L13a
$363,750Barsanjit Mazumder · Cleveland State University · R01 · FY2016 · HL
Mechanisms of Immune Modulation and Periodontal Disease
$363,750Jannet Katz · University Of Alabama At Birmingham · R56 · FY2007 · DE
Defective isoforms of ApoE induce atherogenesis via unfolded protein responses
$363,750Hong Yang · Meharry Medical College · SC1 · FY2017 · HL
Experimental Pathology of Developing Nervous System
$363,750University Of North Carolina Chapel Hill · R01 · FY2004 · NS
Mechanisms of Annexin A6 Mediated Basal-like Breast Cancer Progression
$363,750Amos Malle Sakwe · Meharry Medical College · SC1 · FY2023 · GM
Defective isoforms of ApoE induce atherogenesis via unfolded protein responses
$363,750Hong Yang · Meharry Medical College · SC1 · FY2015 · HL
Translational Silencing in Monocytes: Role of L13a
$363,750Barsanjit Mazumder · Cleveland State University · R01 · FY2018 · HL
Translational Silencing in Monocytes: Role of L13a
$363,750Barsanjit Mazumder · Cleveland State University · R01 · FY2017 · HL
Translational Silencing in Monocytes: Role of L13a
$363,750Barsanjit Mazumder · Cleveland State University · R01 · FY2019 · HL
An Exome-Focused Approach to Pharmacogenetic Analysis of the ACCORD Trial
$363,729John B Buse · Univ Of North Carolina Chapel Hill · R01 · FY2015 · HL
COLUMBIA CENTER FOR HEALTH OF URBAN MINORITIES (CHUM)
$363,639Jose A Luchsinger · Columbia University Health Sciences · P60 · FY2009 · MD
Juvenile Protective Factors and Their Effects on Aging
$363,637Shumei S Sun · Virginia Commonwealth University · R01 · FY2019 · AG
Lipid Transfer Mechanisms
$363,625Baylor College Of Medicine · R01 · FY2002 · HL
Proinflammatory Effects of CD44 on Atherosclerosis
$363,600Wistar Institute · R01 · FY2004 · HL
Role of bile acid receptors FXR and TGR5 in preventing injury in short bowel syndrome
$363,600Ajay K. Jain · Saint Louis University · R01 · FY2024 · DK
Caveolins and Heart Failure
$363,559David M Roth · Veterans Medical Research Fdn/San Diego · P01 · FY2014 · HL
CORE--METABOLIC
$363,537Jacob E Friedman · University Of Colorado Denver · P30 · FY2009 · DK
Glutathione, macrophages and unstable atherosclerosis
$363,520University Of Washington · R01 · FY2004 · HL
Program in Macromolecular Structure, Motion, Control
$363,476Thomas Arthur Steitz · Yale University · P01 · FY2008 · GM